Daria B. Kokh

National Cancer Registry — Ireland

Biochemistry, Genetics and Molecular Biology · Life Sciences

31h-index3.5kcitations140works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Structure and Dynamics(35), Computational Drug Discovery Methods(32), Advanced Chemical Physics Studies(21), Spectroscopy and Laser Applications(13), Receptor Mechanisms and Signaling(13)

Publications140 total

Use of bevacizumab for patients with International Federation of Gynecology and Obstetrics stage IIIB to IV epithelial ovarian cancer undergoing primary debulking surgery and its association with oncologic outcomes: a Cancer Registry study
International Journal of Gynecological Cancer·2025Open Access
852P Evaluating neoadjuvant options in synchronous mCRC RAS mutated or right-sided RAS wild type: A real-world perspective
Annals of Oncology·2025
Correction to “Brownian Dynamics Simulations of Proteins in the Presence of Surfaces: Long-Range Electrostatics and Mean-Field Hydrodynamics”
Journal of Chemical Theory and Computation·2025
Abstract P3-09-09: Axillary staging techniques and oncologic outcomes for breast cancer patients with high clinical nodal burden undergoing neoadjuvant systemic therapy: A cancer registry study
Clinical Cancer Research·2025
Molekulare Tumordiagnostik beim metastasierten Mammakarzinom in Baden-Württemberg – eine Registeranalyse
Senologie - Zeitschrift für Mammadiagnostik und -therapie·2025
161P Oncologic outcomes of hypofractionated vs conventionally fractionated radiotherapy in breast cancer patients with an indication for regional nodal irradiation: A cancer registry study
ESMO Open·2025Open Access
Outcomes of Pembrolizumab plus chemotherapy for patients with metastatic non-squamous NSCLC: Real-world evidence
Pulmonology·2025· 6 citedOpen Access
Prognostic value of the CRM-status in pancreatic ductal adenocarcinoma - data from a regional cancer registry
BMC Cancer·2024· 2 citedOpen Access
Use of chemotherapy and loco‐regional therapy in stage IA triple‐negative breast cancer and their association with oncologic outcomes: A cancer registry study
International Journal of Cancer·2024Open Access
Computational screening of the effects of mutations on protein-protein off-rates and dissociation mechanisms by τRAMD
Communications Biology·2024· 6 citedOpen Access
69P Use of bevacizumab for patients with FIGO stage IIIB to IV epithelial ovarian cancer undergoing primary debulking surgery and its association with oncologic outcomes: A German cancer registry study
ESMO Open·2024Open Access
Use of chemotherapy and loco-regional therapy for stage IA triple-negative breast cancer and their association with oncologic outcomes: A cancer registry study.
Journal of Clinical Oncology·2024
Oncologic Outcomes for Different Axillary Staging Techniques in Patients with Nodal-Positive Breast Cancer Undergoing Neoadjuvant Systematic Treatment: A Cancer Registry Study
Annals of Surgical Oncology·2024· 8 citedOpen Access
Use of Chemotherapy and Loco-regional Therapy for Stage IA triple-negative Breast Cancer and their Association with Oncologic Outcomes: A Cancer Registry Study
Senologie - Zeitschrift für Mammadiagnostik und -therapie·2024
140P Use of chemotherapy and loco-regional therapy for stage IA triple-negative breast cancer and their association with oncologic outcomes: A cancer registry study
ESMO Open·2024Open Access
Computational screening of the effects of mutations on protein-protein off-rates and dissociation mechanisms by τRAMD
2024· 1 citedOpen Access
Prognostic value of the CRM status in pancreatic ductal adenocarcinoma: Data from a regional cancer registry.
Journal of Clinical Oncology·2024
Real-World Outcomes of Pembrolizumab Plus Chemotherapy in Metastatic Non-Squamous Non-Small Cell Lung Cancer a Comparative Analysis with Keynote189 Clinical Trial
SSRN Electronic Journal·2024Open Access
A community effort in SARS‐CoV‐2 drug discovery
Molecular Informatics·2023· 17 citedOpen Access
Präzisionsonkologie in der Versorgungsrealität am Beispiel des Kolonkarzinoms
Die Onkologie·2023
page 1 of 7Next →

Frequent Co-authors

Rebecca C. Wade(29), Robert J. Buenker(9), Nikita Bibinov(8), A.M. Pravilov(7), Aleksey B. Alekseyev(6), Stefan Richter(5), Marta Amaral(4), Matthias Frech(4), Stefano Corni(4), Heinz–Peter Liebermann(4), Musa Ozboyaci(3), S. Kashif Sadiq(3), Ariane Nunes‐Alves(3), Julia Romanowska(3), K. Wiesemann(3), M. E. Akopyan(3), M.B. Stepanov(3), Jerry L. Whitten(3), Antonia Stank(2), Jonathan C. Fuller(2)